ATKR
ATKR: James Wilbert W Jr discloses securities transactions
James Wilbert W Jr reported Disposition to issuer in Atkore Inc.: 17190.9403 units of Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
LoadingLoadingLoadingATKR
James Wilbert W Jr reported Disposition to issuer in Atkore Inc.: 17190.9403 units of Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
ATKR
Zeffiro A Mark reported Disposition to issuer in Atkore Inc.: 23993.8064 units of Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
TENX
ADAR1 Capital Management, LLC; Schneeberger Daniel reported Purchase in TENAX THERAPEUTICS, INC.: 336528 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
NIKI
Sheinerman Kira reported Grant or award in Niki BioSolutions, Inc.: 8000 units of Stock Options (derivative), dated 2026-07-22. The full Form 4 contains 1 transaction entry.
NIKI
Sheinerman Kira reported Grant or award in Niki BioSolutions, Inc.: 8000 units of Stock Options (derivative), dated 2026-07-22. The full Form 4 contains 1 transaction entry.
UFI
MOORE BRIAN DAVID reported Other (see filing) in UNIFI INC: 7 units of Common Stock, dated 2025-10-22. The full Form 4 contains 1 transaction entry.
BLND
Ghamsari Nima reported Sale in Blend Labs, Inc.: 27775 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
OFRM
Morris Scott James reported 3,806 shares of Common Stock in Once Upon a Farm, PBC as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
SNX
Thompson Reyna reported Sale in TD SYNNEX CORP: 200 units of Common Stock, dated 2026-10-20. The full Form 4 contains 6 transaction entries.
GTLB
Sijbrandij Sytse reported Sale in Gitlab Inc.: 73459 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
PETV
A.L. Sarroff Fund, LLC reported Purchase in PetVivo Holdings, Inc.: 9000 units of Common Stock, dated 2026-10-13. The full Form 4 contains 14 transaction entries.
XYL
Emmerich Meredith reported Tax/exercise withholding in Xylem Inc.: 837 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
CARG
Mandel Matthew Charles reported 175,083 shares of Class A Common Stock in CarGurus, Inc. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
STRR
Eberwein Jeffrey E. reported Sale in Star Equity Holdings, Inc.: 1000 units of Series A Preferred Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
DSM
Saba Capital Management, L.P. reported Purchase in BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.: 14573 units of Common Stock, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
NTRS
Qureshi Rima reported 495 shares of Common Stock in NORTHERN TRUST CORP as grants or awards dated 2026-10-20. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
HQ
Fitzsimons Catherine Michele reported Grant or award in Horizon Quantum Holdings Ltd.: 601932 units of Stock Option (Right to Buy) (derivative), dated 2026-06-11. The full Form 4 contains 1 transaction entry.
DNA
Kelly Jason R reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 55694 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 5 transaction entries.
DNA
Shetty Reshma P. reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 29279 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 10 transaction entries.
DNA
Canton Barry reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 26802 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 10 transaction entries.
DNA
Coen Steven P. reported Exercise or conversion in Ginkgo Bioworks Holdings, Inc.: 1174 units of Class A Common Stock, dated 2026-10-16. The full Form 4 contains 5 transaction entries.
INTA
HALL JOHN T reported Exercise or conversion in Intapp, Inc.: 3000 units of Common Stock, dated 2026-10-19. The full Form 4 contains 4 transaction entries.
VRXA
Ziegler Christoph Samuel reported Purchase in Veraxa Biotech AG - Post de-SPAC: 30000 units of Ordinary Shares, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
IKT
Wasserman Scott M. reported Grant or award in Inhibikase Therapeutics, Inc.: 310000 units of Stock Option (Right to Buy) (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
